Vitamin D deficiency and essential hypertension

Songcang Chen, Yingxian Sun, Devendra K. Agrawal

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Essential hypertension (EH) results when the balance between vasoconstriction and vasodilation is shifted in favor of vasoconstriction. This balance is controlled by the interaction of genetic and epigenetic factors. When there is an unstable balance, Vitamin D deficiency as an epigenetic factor triggers a shift to the side of vasoconstriction. In this article, we critically analyze clinical findings on the effect of Vitamin D on blood pressure, combined with progress in molecular mechanisms. We find that Vitamin D repletion exerts a clinically significant antihypertensive effect in Vitamin D-deficient EH patients. Of note, a few trials reported no antihypertensive effect from Vitamin D due to suboptimal study design. Short-term Vitamin D supplementation has no effect on blood pressure in normotensive subjects. This could explain the mixed results and may provide a theoretical basis for future trials to identify beneficial effects of Vitamin D in intervention for EH.

Original languageEnglish
Pages (from-to)885-901
Number of pages17
JournalJournal of the American Society of Hypertension
Volume9
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Vitamin D Deficiency
Vitamin D
Vasoconstriction
Epigenomics
Antihypertensive Agents
Blood Pressure
Vasodilation
Essential Hypertension

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Vitamin D deficiency and essential hypertension. / Chen, Songcang; Sun, Yingxian; Agrawal, Devendra K.

In: Journal of the American Society of Hypertension, Vol. 9, No. 11, 01.11.2015, p. 885-901.

Research output: Contribution to journalReview article

@article{3e5b740875774e4bbcd8ebee78f906cb,
title = "Vitamin D deficiency and essential hypertension",
abstract = "Essential hypertension (EH) results when the balance between vasoconstriction and vasodilation is shifted in favor of vasoconstriction. This balance is controlled by the interaction of genetic and epigenetic factors. When there is an unstable balance, Vitamin D deficiency as an epigenetic factor triggers a shift to the side of vasoconstriction. In this article, we critically analyze clinical findings on the effect of Vitamin D on blood pressure, combined with progress in molecular mechanisms. We find that Vitamin D repletion exerts a clinically significant antihypertensive effect in Vitamin D-deficient EH patients. Of note, a few trials reported no antihypertensive effect from Vitamin D due to suboptimal study design. Short-term Vitamin D supplementation has no effect on blood pressure in normotensive subjects. This could explain the mixed results and may provide a theoretical basis for future trials to identify beneficial effects of Vitamin D in intervention for EH.",
author = "Songcang Chen and Yingxian Sun and Agrawal, {Devendra K.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.jash.2015.08.009",
language = "English",
volume = "9",
pages = "885--901",
journal = "Journal of the American Society of Hypertension",
issn = "1933-1711",
publisher = "Elsevier Ireland Ltd",
number = "11",

}

TY - JOUR

T1 - Vitamin D deficiency and essential hypertension

AU - Chen, Songcang

AU - Sun, Yingxian

AU - Agrawal, Devendra K.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Essential hypertension (EH) results when the balance between vasoconstriction and vasodilation is shifted in favor of vasoconstriction. This balance is controlled by the interaction of genetic and epigenetic factors. When there is an unstable balance, Vitamin D deficiency as an epigenetic factor triggers a shift to the side of vasoconstriction. In this article, we critically analyze clinical findings on the effect of Vitamin D on blood pressure, combined with progress in molecular mechanisms. We find that Vitamin D repletion exerts a clinically significant antihypertensive effect in Vitamin D-deficient EH patients. Of note, a few trials reported no antihypertensive effect from Vitamin D due to suboptimal study design. Short-term Vitamin D supplementation has no effect on blood pressure in normotensive subjects. This could explain the mixed results and may provide a theoretical basis for future trials to identify beneficial effects of Vitamin D in intervention for EH.

AB - Essential hypertension (EH) results when the balance between vasoconstriction and vasodilation is shifted in favor of vasoconstriction. This balance is controlled by the interaction of genetic and epigenetic factors. When there is an unstable balance, Vitamin D deficiency as an epigenetic factor triggers a shift to the side of vasoconstriction. In this article, we critically analyze clinical findings on the effect of Vitamin D on blood pressure, combined with progress in molecular mechanisms. We find that Vitamin D repletion exerts a clinically significant antihypertensive effect in Vitamin D-deficient EH patients. Of note, a few trials reported no antihypertensive effect from Vitamin D due to suboptimal study design. Short-term Vitamin D supplementation has no effect on blood pressure in normotensive subjects. This could explain the mixed results and may provide a theoretical basis for future trials to identify beneficial effects of Vitamin D in intervention for EH.

UR - http://www.scopus.com/inward/record.url?scp=84947029143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947029143&partnerID=8YFLogxK

U2 - 10.1016/j.jash.2015.08.009

DO - 10.1016/j.jash.2015.08.009

M3 - Review article

VL - 9

SP - 885

EP - 901

JO - Journal of the American Society of Hypertension

JF - Journal of the American Society of Hypertension

SN - 1933-1711

IS - 11

ER -